文献速递生殖医学妇科

去甲肾上腺素再摄取抑制剂恢复猕猴功能性下丘脑性闭经模型的排卵及其神经生物学

Neuro-pharmacological reinstatement of ovulation and associated neurobiology in a macaque model of functional hypothalamic amenorrhoea.
PubMed 文献 · Hum Reprod · 2021-01-01

在27只成年雌性食蟹猴的功能性下丘脑性闭经(FHA)模型中,应激敏感个体在应激期间停止排卵,下丘脑去甲肾上腺素(NE)、kisspeptin和GnRH增加;使用NE再摄取抑制剂瑞波西汀(REB)可恢复应激期间排卵并降低上述神经标志物,而艾司西酞普兰无效。

要点

  • 应激敏感猕猴下丘脑NE、kisspeptin和GnRH在卵泡早期升高。
  • REB在应激期间恢复10只应激敏感动物中9只的排卵。
  • REB显著降低下丘脑DBH/NE、kisspeptin和GnRH轴突密度。

核心结论

  • 在食蟹猴FHA模型中,瑞波西汀可恢复应激期间的排卵并逆转下丘脑NE、kisspeptin和GnRH的升高。

研究设计与样本

  • 纵向设计,27只成年(7-13岁)雌性食蟹猴,按应激敏感性分三组,监测三个90天周期组。
  • 每个周期组含一个无应激排卵周期和两个应激周期(共60天),个体接受安慰剂、艾司西酞普兰或瑞波西汀。
  • 部分动物在应激期间接受CIT或REB治疗后安乐死,取 hypothalamus 进行免疫组化,血清孕酮用放射免疫法测定。

主要发现

  • 瑞波西汀在应激期间恢复10只应激敏感动物中9只的排卵。
  • 瑞波西汀在最具应激敏感性组显著增加应激期间孕酮分泌(P = 0.032),提示排卵。
  • 艾司西酞普兰无效。
  • 与CIT相比,REB在月经周期第5天显著降低应激敏感和弹性组下丘脑DBH/NE、kisspeptin和GnRH轴突密度(P = 0.003、0.018和0.0001)。

临床怎么用

  • 在FHA动物模型中,靶向升高的NE(使用NRI)可能恢复排卵,而非直接用促性腺激素绕过下丘脑。
  • REB尚未获美国FDA批准用于人类,欧洲用于抑郁/焦虑(EdronaxTR),对女性FHA的疗效未确定。

局限性

  • 美国FDA未批准REB用于人类,虽在欧洲用于抑郁/焦虑治疗。
  • REB是否对女性FHA有用尚未确定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: What is the underlying neuropathology in a cynomolgus macaque model of functional hypothalamic amenorrhoea (FHA) and can it be normalized to restore ovulation? SUMMARY ANSWER: Anovulatory monkeys exhibited increased hypothalamic norepinephrine (NE), kisspeptin and gonadotropin-releasing hormone (GnRH) in the early follicular phase, but administration of the NE reuptake inhibitor (NRI), reboxetine (REB), restored ovulation during stress and normalized NE, kisspeptin and GnRH. WHAT IS KNOWN ALREADY: Female cynomolgus macaques, like women, show individual reproductive sensitivity to modest psychosocial and metabolic stress. During stress, resilient females ovulate through two menstrual cycles whereas stress-sensitive (SS) macaques immediately cease ovulation. On Day 5 of a non-stressed menstrual cycle, resilient macaques have less NE synthesizing enzyme [dopamine β-hydroxylase (DBH)], kisspeptin and GnRH innervation of the medial basal hypothalamus but more endogenous serotonin than SS macaques. Stress increased DBH/NE, kisspeptin and GnRH but did not alter serotonin. STUDY DESIGN, SIZE, DURATION: In a longitudinal design, 27 adult (7-13 years) female cynomolgus macaques (Macaca fascicularis) with three different levels of sensitivity to stress were monitored with daily vaginal swabs and frequent serum progesterone (P) measurements. Three 90-day experimental periods called 'Cycle Sets' were monitored. A Cycle Set consisted of one ovulatory menstrual cycle without stress, and two cycles, or 60 days, with modest stress. Each Cycle Set was followed by a rest period. During a Cycle Set, individuals were either untreated (placebo) or administered escitalopram (CIT) or REB. Ultimately, half of each sensitivity group was euthanized during stress with CIT or REB treatment and the hypothalamus was obtained. Neurobiological endpoints were compared between CIT and REB treatment groups in stress resilient and SS monkeys. PARTICIPANTS/MATERIALS, SETTING, METHODS: The monkeys were housed at the University of Pittsburgh primate facility for the duration of the experiments. Upon euthanasia, their brains and serum samples were shipped to the Oregon National Primate Research Center. The hypothalamus was examined with immunohistochemistry for the expression of DBH (a marker for NE axons), kisspeptin and GnRH. P was measured in the serum samples by radioimmunoassay. MAIN RESULTS AND THE ROLE OF CHANCE: Daily administration of REB restored ovulation in 9 of 10 SS animals during stress. Of note, REB significantly increased P secretion during stress in the most sensitive group (P = 0.032), which indicates ovulation. CIT lacked efficacy. REB significantly reduced DBH/NE, kisspeptin and GnRH axon density in the hypothalamus relative to CIT treatment (P = 0.003. 0.018 and 0.0001, respectively) on Day 5 of the menstrual cycle in resilient and sensitive groups. LARGE SCALE DATA: N/A. LIMITATIONS, REASONS FOR CAUTION: The US FDA has not approved REB for human use, although it is used in Europe for the treatment of depression/anxiety as EdronaxTR. Whether REB could be useful for the treatment of FHA in women has not been determined. WIDER IMPLICATIONS FOR THE FINDINGS: The use of an NRI to treat FHA is a novel approach and the potential reinstatement of ovulation could be straightforward compared to current treatment protocols. The underlying neurobiology provides a compelling case for treating the origin of the pathology, i.e. elevated NE, rather than circumventing the hypothalamus altogether with gonadotropins, which have associated risks such as hyperstimulation syndrome or multiple births. STUDY FUNDING/COMPETING INTEREST(S): Portions of this study were supported by NIH grant HD062864 to C.L.B., NIH grant HD62618 to J.L.C. and C.L.B. and 1P51 OD011092 for the operation of the Oregon National Primate Research Center. There were no competing interests.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Bethea CL, Cameron JL. Neuro-pharmacological reinstatement of ovulation and associated neurobiology in a macaque model of functional hypothalamic amenorrhoea. Hum Reprod. 2021. PMID: 33319240. doi:10.1093/humrep/deaa296

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。